The Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, New Territories, Hong Kong, SAR, China.
Breast Disease Center, The First Affiliated Hospital of Nanchang University, Nanchang, China.
J Clin Nurs. 2024 Dec;33(12):4554-4567. doi: 10.1111/jocn.17479. Epub 2024 Oct 11.
Breast cancer patients experience various adverse symptoms during adjuvant chemotherapy. These adverse symptoms often form symptom clusters and have a negative impact on patients.
To summarise common symptom clusters in different dimensions and their longitudinal changes among breast cancer patients receiving adjuvant chemotherapy.
A systematic review.
Ten electronic databases were searched from 2001 to January 2024, and the search was last updated on 16 August 2024.
Two reviewers independently assessed the eligibility of each study and extracted data. The Standard Quality Assessment Criteria for Evaluating Primary Research Papers was used to evaluate the quality of included studies. The findings were synthesised narratively. This systematic review has been registered (CRD42022370210).
Nine studies with a total of 1454 participants were included. The common symptom clusters in breast cancer patients receiving adjuvant chemotherapy were the gastrointestinal symptom cluster (nausea-lack of appetite), the fatigue-pain-sleep disturbance symptom cluster and the psychological symptom cluster (worry-sadness-nervousness-distress-feeling irritable-difficult concentrating). The severity dimension was the most frequently utilised in identifying symptom clusters, with the number and concurrence of symptom clusters showing variation over time.
This study summarised common symptom clusters in breast cancer patients receiving adjuvant chemotherapy and revealed their changes from symptom dimensions and the chemotherapy process. These findings support further exploration of symptom cluster changes and underlying mechanisms, facilitating the design of targeted management strategies, including appropriate interventions and measurement dimensions in clinical nursing, to ultimately reduce patients' symptom burden.
Common symptom clusters have been identified in breast cancer patients receiving adjuvant chemotherapy. Clinical nursing in oncology can prioritise these symptom clusters and provide patients with targeted management strategies.
PRISMA guidelines and SWiM guidelines.
No patient or public contribution.
乳腺癌患者在接受辅助化疗时会经历各种不良反应。这些不良反应常常形成症状群,对患者产生负面影响。
总结接受辅助化疗的乳腺癌患者不同维度的常见症状群及其纵向变化。
系统综述。
从 2001 年至 2024 年 1 月,检索了 10 个电子数据库,并于 2024 年 8 月 16 日进行了最新检索。
两名审查员独立评估每项研究的纳入标准并提取数据。使用标准质量评估标准评估纳入研究的质量。研究结果以叙述性方式进行综合。本系统评价已在 CRD42022370210 注册。
纳入了 9 项研究,共 1454 名参与者。接受辅助化疗的乳腺癌患者常见的症状群包括胃肠道症状群(恶心-食欲不振)、疲劳-疼痛-睡眠障碍症状群和心理症状群(担忧-悲伤-紧张-苦恼-烦躁不安-注意力不集中)。严重程度维度是最常用于识别症状群的维度,症状群的数量和并发随时间而变化。
本研究总结了接受辅助化疗的乳腺癌患者的常见症状群,并揭示了它们在症状维度和化疗过程中的变化。这些发现支持进一步探索症状群的变化及其潜在机制,有助于设计针对管理策略,包括在临床护理中选择适当的干预措施和测量维度,最终减轻患者的症状负担。
已经确定了接受辅助化疗的乳腺癌患者的常见症状群。肿瘤学临床护理可以优先考虑这些症状群,并为患者提供有针对性的管理策略。
PRISMA 指南和 SWiM 指南。
无患者或公众贡献。